Literature DB >> 26165618

Use of zebrafish as a model to investigate the role of epigenetics in propagating the secondary complications observed in diabetes mellitus.

Michael P Sarras1, Alexey A Leontovich2, Robert V Intine3.   

Abstract

Diabetes mellitus (DM) is classified as a disease of metabolic dysregulation predicted to affect over 400 million individuals world-wide by 2030. The debilitating aspects of this disease are the long term complications involving microvascular and macrovascular pathologies. These long term complications are related to the clinical phenomenon of metabolic memory (MM) that is defined as the persistence of diabetic complications even after glycemic control has been pharmacologically achieved. The persistent nature of MM has invoked involvement of epigenetic processes. Current research with the DM/MM zebrafish model as described in this review as well as human and mammalian studies has established that changes in DNA methylation patterns appear to contribute to tissue dysfunctions associated with DM. This review will describe studies on an adult zebrafish model of type I diabetes mellitus that allows analysis of both the hyperglycemic (HG or DM) phase and MM phase of the disease. The review will discuss the model in regards to: 1) its hyperglycemic phase, 2) its MM phase, 3) biochemical õpathways underlying changes in DNA methylation patterns observed in the model, 4) loci specific changes in DNA methylation patterns, and 5) strengths of the adult zebrafish model as compared to other MM animal models.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Epigenetics; Metabolic memory; Zebrafish

Mesh:

Year:  2015        PMID: 26165618      PMCID: PMC4662881          DOI: 10.1016/j.cbpc.2015.07.001

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Toxicol Pharmacol        ISSN: 1532-0456            Impact factor:   3.228


  34 in total

1.  Effects of high or low dose of streptozocin on pancreatic islets in C57BL/6 and C.B17-SCID mice.

Authors:  W T Lu; J H Juang; B R Hsu; H S Huang
Journal:  Transplant Proc       Date:  1998-03       Impact factor: 1.066

2.  Inhibition of poly-ADP ribose polymerase enzyme activity prevents hyperglycemia-induced impairment of angiogenesis during wound healing.

Authors:  Michael P Sarras; Samantha Mason; Geoffrey McAllister; Robert V Intine
Journal:  Wound Repair Regen       Date:  2014 Sep-Oct       Impact factor: 3.617

3.  Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

Authors:  R C Turner; C A Cull; V Frighi; R R Holman
Journal:  JAMA       Date:  1999-06-02       Impact factor: 56.272

Review 4.  Role of oxidative stress in development of complications in diabetes.

Authors:  J W Baynes
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

5.  Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats.

Authors:  Renu A Kowluru
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

6.  Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat.

Authors:  H P Hammes; I Klinzing; S Wiegand; R G Bretzel; A M Cohen; K Federlin
Journal:  Invest Ophthalmol Vis Sci       Date:  1993-05       Impact factor: 4.799

7.  Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory.

Authors:  S Roy; R Sala; E Cagliero; M Lorenzi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

8.  Progression of incipient diabetic retinopathy during good glycemic control.

Authors:  R L Engerman; T S Kern
Journal:  Diabetes       Date:  1987-07       Impact factor: 9.461

9.  Studies of streptozotocin-induced insulitis and diabetes.

Authors:  A A Rossini; A A Like; W L Chick; M C Appel; G F Cahill
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

10.  Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.

Authors:  B A O'Brien; B V Harmon; D P Cameron; D J Allan
Journal:  J Pathol       Date:  1996-02       Impact factor: 7.996

View more
  3 in total

Review 1.  Fishing for Nature's Hits: Establishment of the Zebrafish as a Model for Screening Antidiabetic Natural Products.

Authors:  Nadia Tabassum; Hongmei Tai; Da-Woon Jung; Darren R Williams
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-23       Impact factor: 2.629

2.  Doxazosin attenuates renal matrix remodeling mediated by anti-α1-adrenergic receptor antibody in a rat model of diabetes mellitus.

Authors:  Lin-Shuang Zhao; Yan-Yan Lin; Yi Liu; Chun-Yan Xu; Ye Liu; Wei-Wei Bai; Xue-Ying Tan; De-Zhong Li; Jin-Ling Xu
Journal:  Exp Ther Med       Date:  2017-07-21       Impact factor: 2.447

3.  Frequency of Gestational Diabetes Mellitus Reappearance or Absence during the Second Pregnancy of Women Treated at Mayo Clinic between 2013 and 2018.

Authors:  Elizabeth Ann L Enninga; Aoife M Egan; Layan Alrahmani; Alexey A Leontovich; Rodrigo Ruano; Michael P Sarras
Journal:  J Diabetes Res       Date:  2019-11-22       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.